View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AS85 | Publication ID: Spring 2016 |
Title: ●Part B Drug Payment Model (CMS-1670-F) | |
Abstract:
This final rule implements the Part B Drug Payment Model, which is a two-phase model that tests whether alternative drug payment designs will lead to a reduction in Medicare expenditures, while preserving or enhancing the quality of care provided to Medicare beneficiaries. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 42 CFR 511 | |
Legal Authority: 42 U.S.C. 1302, 1315(a), and 1395hh |
Legal Deadline:
|
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Rasheeda Johnson Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C4-01-26, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-3434 Email: rasheeda.johnson@cms.hhs.gov |